Evidence for the occurrence of the malate-citrate shuttle in intact Ehrlich ascites tumor cells.
A possible activity of the malate-citrate shuttle has been investigated in Ehrlich ascites cells by testing the effects of 1,2,3-benzenetricarboxylic acid, an inhibitor of the malate-citrate exchange, and (-)-hydroxycitrate, an inhibitor of the citrate cleavage enzyme, on the glucose-dependent oxidation-reduction rates of pyridine nucleotides and cytochrome b as well as two inhibitors glycolyzing cells. Moreover, to quantitate such an activity, the effects of these two inhibitors have been compared with those induced under the same experimental conditions by aminooxyacetate, an inhibitor of the malate-aspartate shuttle which is known to operate in this strain of ascites tumor. Both benzenetricarboxylic acid and hydroxycitrate are able to increase the reduction of pyridine nucleotides, which follows glucose addition to whole cells, to about the same extent. A much more pronounced effect is elicited by aminooxyacetate under the same condition. When n-butylmalonate is added to slow down the flux of glycolytic reducing equivalents to the respiratory chain via the malate-aspartate shuttle, benzenetricarboxylic acid or hydroxycitrate promotes an ATP-driven reversal of electron transfer. Indeed, the glucose induced reduction of cytochrome b becomes sensitive to oligomycin and the ATP level is raised significantly with respect to the value of uninhibited cells. It is concluded that the malate-citrate shuttle operates in Ehrlich ascites cells, although with a substantially lower activity with respect to the malate-aspartate shuttle.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D001555:Benzene Derivatives / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D002951:Citrates / Q000378:metabolism* / Q000494:pharmacology*; D019343:Citric Acid; D003573:Cytochrome b Group; D003580:Cytochromes / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects; D007700:Kinetics; D008293:Malates / Q000378:metabolism*; D051379:Mice; D010084:Oxidation-Reduction; D014233:Tricarboxylic Acids / Q000494:pharmacology*
D001555:Benzene Derivatives; D002951:Citrates; D003573:Cytochrome b Group; D003580:Cytochromes; D008293:Malates; D014233:Tricarboxylic Acids; D000625:Aminooxyacetic Acid; D019343:Citric Acid; C004288:benzene 1,2,3-tricarboxylic acid; C030298:malic acid; D000255:Adenosine Triphosphate; C007999:hydroxycitric acid